» Articles » PMID: 1345742

On the Role of Interleukin-2 (IL-2) in Multiple Sclerosis (MS). IL-2-mediated Endothelial Cell Activation

Overview
Specialty Neurology
Date 1992 Dec 1
PMID 1345742
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Increased serum levels of IL-2 and sIL-2R can be demonstrated in patients with active MS, a finding that strongly supports the hypothesis of a systemic T cell activation in such patients. However, IL-2 may play a crucial role in MS immunopathology by activating endothelial cells, as suggested by the vascular leak syndrome complicating hrIL-2 therapy. Early BBB impairment and focal perivascular edema that characterize MS lesions may be the effect of an IL-2-induced cytokine cascade.

Citing Articles

Thermoregulatory dynamics reveal sex-specific inflammatory responses to experimental autoimmune encephalomyelitis in mice: Implications for multiple sclerosis-induced fatigue in females.

Faraji J, Bettenson D, Babatunde S, Gangur-Powell T, Yong V, Metz G Brain Behav Immun Health. 2022; 23:100477.

PMID: 35677535 PMC: 9167694. DOI: 10.1016/j.bbih.2022.100477.


Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis-A Possible Cause of Constitutive NF-κB Activation.

Yan J, McCombe P, Pender M, Greer J J Clin Med. 2020; 9(8).

PMID: 32781504 PMC: 7465818. DOI: 10.3390/jcm9082534.


Interleukin 2 Activates Brain Microvascular Endothelial Cells Resulting in Destabilization of Adherens Junctions.

Wylezinski L, Hawiger J J Biol Chem. 2016; 291(44):22913-22923.

PMID: 27601468 PMC: 5087713. DOI: 10.1074/jbc.M116.729038.


Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Morris G, Maes M BMC Med. 2013; 11:205.

PMID: 24229326 PMC: 3847236. DOI: 10.1186/1741-7015-11-205.


Macaques with rapid disease progression and simian immunodeficiency virus encephalitis have a unique cytokine profile in peripheral lymphoid tissues.

Orandle M, Williams K, MacLean A, Westmoreland S, Lackner A J Virol. 2001; 75(9):4448-52.

PMID: 11287599 PMC: 114195. DOI: 10.1128/JVI.75.9.4448-4452.2001.